Inclusion of CD8α ALN-1 in a prophylactic H3N2-based influenza vaccine fully protects mice against challenge infection with a high dose of a heterosubtypic pH1N1 influenza A virus, which correlated with the induction of strong, functional and long-lasting antiviral T cell responses. The gene discussed is CD8A; the disease is influenza.